Tech Company Inital Public Offerings

Ventyx Biosciences IPO

Ventyx Biosciences, operating out of Encinitas, offered its shares in an initial public offering on 10/21/2021.

Transaction Overview

Company Name
Announced On
10/21/2021
Transaction Type
IPO
Amount
$151,500,000
Proceeds Purpose
We currently intend to use the net proceeds from this offering to fund the clinical development of VTX958; to fund the clinical development of VTX002; to fund the clinical development of VTX2735; to fund research activities and preclinical development of our other development programs; and for business development activities, working capital needs and other general corporate purposes. We may also use a portion of our net proceeds to acquire, license or invest in complementary products, technologies, or businesses.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
662 Encinitas Blvd. 250
Encinitas, CA 92024
USA
Phone
Undisclosed
Email Address
Overview
We are a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.
Profile
Ventyx Biosciences LinkedIn Company Profile
Social Media
Ventyx Biosciences Company Twitter Account
Company News
Ventyx Biosciences News
Facebook
Ventyx Biosciences on Facebook
YouTube
Ventyx Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Raju Mohan
  Raju Mohan LinkedIn Profile  Raju Mohan Twitter Account  Raju Mohan News  Raju Mohan on Facebook
Chief Medical Officer
Dick Gregg
  Dick Gregg LinkedIn Profile  Dick Gregg Twitter Account  Dick Gregg News  Dick Gregg on Facebook
Chief Scientific Officer
John Nuss
  John Nuss LinkedIn Profile  John Nuss Twitter Account  John Nuss News  John Nuss on Facebook
Vice President
Kathy Ogilvie
  Kathy Ogilvie LinkedIn Profile  Kathy Ogilvie Twitter Account  Kathy Ogilvie News  Kathy Ogilvie on Facebook
VP - Bus. Development
Chris Krueger
  Chris Krueger LinkedIn Profile  Chris Krueger Twitter Account  Chris Krueger News  Chris Krueger on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/21/2021: Honeycomb venture capital transaction
Next: 10/21/2021: Flock Freight venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary